Glycomics finds applications in developing therapeutic strategies for diseases including diabetes, cancer, and inflammatory conditions. Glycans play an important role in various biological recognition phenomena and disease processes. Advancements in the fields of proteomics and genomics have boosted research activities in glycobiology, thereby driving the demand for glycomics instruments, reagents, and other products.
The Global Glycomics Market Size is estimated to be valued at US$ 1.99 Billion in 2024 and is expected to exhibit a CAGR of 13% over the forecast period from 2024 to 2031.
Glycomics finds widespread usage in drug discovery & development for diseases such as cancer, inflammatory disease, and other rare genetic diseases. Glycans are the major components of antibodies and vaccines. Detailed glycan analysis is important for developing and manufacturing biopharmaceuticals. Glycomics tools aid in developing highly efficient and affordable biotherapeutics and biosimilars.
Key Takeaways
Key players operating in the glycomics market are RayBiotech Life, Inc., Shimadzu Corporation, Asparia Glycomics, Agilent Technologies Inc., Thermo Fisher Scientific, Inc., Bruker Corporation, Merck KgaA, New England Biolabs, Takara Bio Inc, Waters Corporation, Danaher, Lectenz Bio, GlycoMimetics, Inc., Ludger Ltd., GlycoTech Corporation, Glykos, Inc., and Glanbia PLC. These players are adopting strategies such as acquisitions, partnerships, and new product launches to expand their market share.
The glycomics market offers new opportunities in the areas of biomarker discovery, drug testing, and disease diagnostics. Biomarkers identified through glycomics studies could enable non-invasive or fluid-based diagnostics for various conditions. Glycomics is also finding increasing applications in drug development, toxicity testing, pharmacokinetics studies, and personalized medicine.
North America dominates the global glycomics market, followed by Europe. However, Asia Pacific is expected to witness the highest growth during the forecast period. This can be attributed to rising collaborations between international & regional players, increasing healthcare spending, and growing focus on R&D activities in countries such as China, India, and Japan.
Market drivers
One of the key drivers for the glycomics market is the increasing R&D investments made by pharmaceutical and biotechnology companies in glycobiology. Glycans play an important role in several biological pathways and disease processes. Understanding carbohydrate functions through glycomics tools is crucial for developing novel treatment and diagnostic approaches. This has prompted many players to fund glycomics research.
Market restraints
One of the major restraints for the glycomics market is the complexity of glycan structures. Unlike nucleic acids and proteins, glycans exhibit extensive diversities and microheterogeneities, making their analysis challenging. Glycomics techniques also require specialized training which limits their widespread adoption. The high costs of instruments and reagents further inhibit the growth of the glycomics market.
Segment Analysis
The glycomics market is dominated by the disease segment. This segment holds the largest share as glycomics find major applications in disease diagnostics and developing therapeutic drugs. Glycomics analysis help in better understanding of various diseases like cancer, arthritis, cardiovascular diseases etc at molecular level. Identification of distinct glycan patterns in various diseases help in developing targeted drugs and biomarkers for disease diagnostics.
Global Analysis
The North America region holds the largest share in the glycomics market owing to growing research in life sciences, increasing investments in glycomics, and well-established healthcare industry and research infrastructure in the region. The region is anticipated to continue its dominance during the forecast period. However, Asia Pacific is expected to grow at the fastest pace in the glycomics market during the forecast period. Rising geriatric population, increasing healthcare expenditure, improving research infrastructure and economic growth in emerging economies like China and India are driving the market growth in the region.
Get More Insights On This Topic: Glycomics Market
Comments
0 comment